LOGUERCIO, Carmelina
 Distribuzione geografica
Continente #
NA - Nord America 5.398
EU - Europa 5.310
AS - Asia 1.046
SA - Sud America 38
AF - Africa 9
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.811
Nazione #
US - Stati Uniti d'America 5.369
IE - Irlanda 1.660
UA - Ucraina 967
GB - Regno Unito 711
IT - Italia 620
DE - Germania 420
SG - Singapore 384
CN - Cina 280
SE - Svezia 274
FI - Finlandia 244
TR - Turchia 188
GR - Grecia 160
FR - Francia 154
KR - Corea 87
VN - Vietnam 53
BR - Brasile 24
BE - Belgio 22
IN - India 19
RU - Federazione Russa 19
NL - Olanda 17
MX - Messico 14
ES - Italia 11
HK - Hong Kong 10
CA - Canada 9
AU - Australia 8
AT - Austria 5
CL - Cile 5
IR - Iran 5
JP - Giappone 5
MK - Macedonia 5
PK - Pakistan 5
PL - Polonia 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
ID - Indonesia 4
AR - Argentina 3
CH - Svizzera 3
EC - Ecuador 3
RO - Romania 3
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
TW - Taiwan 2
BF - Burkina Faso 1
BO - Bolivia 1
CO - Colombia 1
CU - Cuba 1
JM - Giamaica 1
KE - Kenya 1
MO - Macao, regione amministrativa speciale della Cina 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
Totale 11.811
Città #
Dublin 1.657
Jacksonville 1.453
Chandler 927
Santa Clara 281
Princeton 275
Medford 228
Singapore 217
Boardman 164
Roxbury 149
San Mateo 132
Ann Arbor 128
Wilmington 118
Beijing 101
Woodbridge 87
New York 70
Seoul 64
Cambridge 61
Caserta 57
Naples 57
Des Moines 54
Dong Ket 52
Bremen 47
Nanjing 43
Ashburn 37
Düsseldorf 30
Jinan 24
Mountain View 21
Norwalk 20
Brussels 18
Houston 17
Napoli 16
Boydton 15
Auburn Hills 14
Munich 14
Kunming 13
Redwood City 13
Venice 13
Rome 12
Los Angeles 11
Jinju 10
Shenyang 10
Lanzhou 9
Atella 8
Catania 8
Hong Kong 8
Milan 8
Paris 8
Potenza 8
Groningen 7
Helsinki 7
Nanchang 7
Tianjin 7
Zhengzhou 7
Bologna 6
Changsha 6
Fairfield 6
Madrid 6
Sennori 6
Shanghai 6
Aversa 5
Bovisio 5
Daejeon 5
Hanover 5
Lissone 5
Orange 5
Portici 5
Salerno 5
San Mango 5
Santiago 5
St Petersburg 5
Antwerp 4
Berlin 4
Brno 4
Dallas 4
Falls Church 4
Gyeonggi-do 4
Hangzhou 4
Hebei 4
Moscow 4
Santo Domingo 4
Torino 4
Torre Del Greco 4
Vienna 4
Amsterdam 3
Bari 3
Bisaccia 3
Brescia 3
Celâl 3
Dearborn 3
Dzierzoniow 3
Gatchina 3
Genoa 3
Guangzhou 3
Haikou 3
Jiaxing 3
Lodi 3
Manaus 3
Marano Di Napoli 3
New Delhi 3
Nocera Superiore 3
Totale 7.016
Nome #
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 109
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 107
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 105
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 103
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 99
Intrafamilial spread of Helicobacter pylori infection 94
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 87
Studio nutrizionale del cirrotico. Confronto fra plicometria cutanea ed acqua corporea 79
Gut-Brain Axis: a new revolution to understand the pathogenesis of autism and other severe neurological diseases 76
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 74
Chronic inflammation and oxidative stress in human carcinogenesis 73
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 73
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 70
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 69
A case of hepatotoxicity caused by green tea 69
NUTRITIONAL STATUS IN LIVER CIRRHOSIS 68
Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease 67
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 67
Crohn’s disease and skin 66
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study. 66
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases 66
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 65
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 64
Il “pianeta” fegato grasso nella pratica clinica. Dalla Diagnosi alla terapia 64
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 63
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 63
Trace elements and chronic liver diseases 62
Alterazione della sensibilità gustativa nel diabete mellito 62
L'uomo e il vino 62
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 61
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 61
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 61
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 60
AISF position paper on liver disease and pregnancy 60
Alter Ego: Sindrome metabolica e fegato 59
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 59
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 58
Age affects glutathione content and glutathione-transferase activity in human gastric mucosa 57
Fegato e glutatione 57
Epidemiologia delle epatiti croniche ad eziologia virale. 57
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 57
Alcoholic hepatitis: Pathogenesis, diagnosis and treatment 57
Treatment of chronic hepatic encephalopathy with rifaximin. In: Encefalopatia epatica 56
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 56
age aggects glutathione content and glutathione- transferease activity in human gasstric mucosa 55
Fegato e alcol: un connubio difficile 55
Una spia sulla tavola dei nostri ragazzi 55
Management of chronic liver disease by general practitioners in southern Italy: unmet educational needs 54
Secrezione salivare e tests strumentali di neuropatia diabetica autonoma 54
Alcoholic liver disease and hepatitis C chronic infection 54
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 54
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 53
Effect of gastrin upon salivary flow rate in normal subject, duodenal ulcer and cirrhotic patients. 53
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee 53
About gut microbiota: Why? 53
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 53
Effetti metabolici della silibina: studi in vitro e in vivo. 53
Permeabilità intestinale e malattie epatiche. 53
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 52
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 52
Gut microbiota and the liver 52
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 52
Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures 52
Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: A clinical, molecular, and functional study 51
Sensibilita' gustativa e patologia cronica del fegato 51
Interfences of a symbiotic formulation (FB, Flortec®, Bracco s.p.a., Italy) on a gastric and intestinal permeability in rats with experimentally induced chronic liver damage. 51
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 51
Liver p53 expression in patients with HCV-related chronic hepatitis 50
Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study. 50
Treatment of patients with non-alcoholic fatty liver disease: Current views and perspectives 50
[Diabetic neuropathy. II. Autonomic neuropathy. The gastrointestinal system] 50
alcoholic liver cirrhosis after the advent of hepatits C virus: some reflections on its epidemiology and on the concept of attributable risk 50
Iperbilirubinemia da acido nicotinico: potenziamento da contemporaneo carico di BSF. 50
L'alimentazione nel soggetto con epatite virale acuta e cronica 50
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 50
Creatinine clearance: an inadequate marker of renal filtration in patients with early posthepatitic cirrhosis (Child A) without fluid retention and muscle wasting 49
TPN-related digestive complications in critically ill patients 49
Oxidative stress in viral and alcoholic hepatitis 49
Factors associated with poor health-related quality of life of patients with cirrhosis 49
Inhibitory effect of caerulein on salivary secretion in man 49
Asse intestino-fegato: ruolo della flora batterica e dei probiotici. 49
Il consumo alcolico nella regione Campania: quali le nuove realtà 49
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 49
PITER: An ongoing nationwide study on the real-life impact of direct acting antiviral based treatment for chronic hepatitis C in Italy 49
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 49
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 49
TPN-related digestive alterations. Animal and human data in the non-critical setting 48
[Pentagastrin, a histamine H2 receptor inhibitor, and human salivary secretion] 48
The role of foods as addictive or protective factors in alcohol-induced chronic liver disease 48
Clinical nutrition practice in Italian Gastroenterology Units 48
Antioxidants in the treatment and prevention of gastric mucosal damage 48
Aspetti alimentari, stato nutrizionale e malattie dell’apparato digerente – Interazione nell’età evolutiva e nell’adulto 48
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 47
Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies 47
Focal gastric blood perfusion in relation with the endoscopic signs and liver function in cirrhotic patients 47
Influenza di sesso ed età sulla sensibilita' gustativa in soggetti sani 47
Alcool e mucosa gastrica: ruolo dei composti sulfidrilici 47
Il nostro fegato è sempre più grasso 47
Epidemiology and natural history of alcoholic liver disease 47
A real-life study of new antiviral therapies in a high prevalence geographical area for hepatitis C virus infection 47
Totale 5.887
Categoria #
all - tutte 53.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020865 0 0 0 0 249 22 274 67 123 59 57 14
2020/20212.073 223 10 259 85 298 27 288 241 16 285 229 112
2021/20221.589 142 4 11 48 589 19 31 35 57 52 148 453
2022/20233.277 319 87 34 306 314 262 4 216 1.601 29 53 52
2023/20241.257 119 45 64 126 438 82 45 24 1 19 106 188
2024/2025601 29 77 56 92 347 0 0 0 0 0 0 0
Totale 12.101